XML 38 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings Per Share (Tables)
9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Anti-dilutive stock awards were as follows for the periods presented:
Quarter Ended
September 30,
Nine Months Ended
September 30,
(in thousands)2022202120222021
Stock awards102 — 107 72 
Total102 — 107 72 
Basic And Diluted Earnings Per Share
The following table presents the earnings per share calculation for the periods presented:
 Quarter Ended
September 30,
Nine Months Ended
September 30,
2022202120222021
Net Income Attributable to CME Group (in millions)
$679.6 $926.5 $2,053.1 $2,011.2 
Less: preferred stock dividends(4.6)— (13.8)— 
Less: undistributed earnings allocated to preferred stock(3.9)— (12.1)— 
Net Income Attributable to Common Shareholders of CME Group$671.1 $926.5 $2,027.2 $2,011.2 
Weighted Average Number of Common Shares (in thousands):
Basic358,715 358,363 358,655 358,258 
Effect of stock options, restricted stock and performance shares573 625 551 636 
Diluted359,288 358,988 359,206 358,894 
Earnings per Common Share Attributable to Common Shareholders of CME Group:
Basic$1.87 $2.59 $5.65 $5.61 
Diluted1.87 2.58 5.64 5.60